newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Regains Compliance with NASDAQ Listing Requirements

MALVERN, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced that the Company received a letter on March 3, 20